Navigation Links
GRANISOL™ (Granisetron) Oral Solution Eligible for Medicaid Reimbursement
Date:4/13/2011

ers/granisol

For disclaimer information, visit: http://www.121hm.com/offers/granisol/tandc.html

GRANISOL is indicated for the prevention of:

  • Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.
  • Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

For full prescribing information, visit: http://www.pediatrx.com/products/pdf/granisol_pi.pdf

Selected Safety Information

  • GRANISOL is contraindicated in patients with known hypersensitivity to the drug or any of its components.
  • QT prolongation has been reported with granisetron. Therefore, GRANISOL Oral Solution should be used in caution with patients with pre-existing arrhythmias or cardiac conduction disorders, as this might lead to clinical consequences. Patients with cardiac disease, on cardio-toxic chemotherapy, with concomitant electrolyte abnormalities and/or on concomitant medications that prolong the QT interval are particularly at risk.
  • Safety and effectiveness in pediatric patients have not been established.
  • The most common side effects observed with administration of granisetron were headache, asthenia, constipation, diarrhea, dyspepsia, and abdominal pain.

*2009 U.S. Census Bureau.

For further information related to material contained in this release, please contact Holmes World Media Inc., +1 512 981 7369

About PediatRx, Inc.

PediatRx, Inc. (www.pediatrx.com) is a hospital specialty pharmaceutical company which focuses on treatments for patients suffering from serious conditions requir
'/>"/>

SOURCE PediatRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies
2. UC San Diego chemists produce first high-resolution RNA nano square
3. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
4. Perceptive Informatics Introduces DataLabs® 5.0 EDC Solution, Unlocking New Clinical Trial Process Efficiencies
5. Announcing ValGenesis On-Demand SaaS Solution
6. Finesse Solutions Introduces New T700 cGMP Upstream Processing Platform Featuring G3 Hardware and Fully Integrated Single-Use Sensors
7. Finesse Solutions Showcases SmartBag with Fully Integrated Single-Use pH and pO2 Sensors for Rocker Bioreactors at Interphex 2011
8. M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches M3Clinician.com
9. D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology
10. 3-D nanoparticle in atomic resolution
11. A nano-solution to global water problem: Nanomembranes could filter bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... CAMBRIDGE, England, October 12 Crescendo Biologics,("Crescendo") today ... to advance the development of its fragment antibody technology,platforms. ... Paris-based,venture capital firm, with Aitua, Avlar BioVentures and the ... Crescendo brings together highly innovative in vivo and in ...
... , SAN FRANCISCO, Oct. 12 Dr. Michael ... implant inventor, brain plasticity expert and ... Medicine (IOM) today in Washington, D.C. Also a member of ... a small group of scientists and doctors in the U.S. ...
... ANA, Calif., Oct. 12 Selexis SA ("Selexis") and ... present results of a recent collaborative effort combining the ... IS CHO Culture System, demonstrating the rapid production of ... cell lines. Irvine and Selexis will jointly present ...
Cached Biology Technology:Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 2Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 3Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 4Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 2Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 3Irvine Scientific and Selexis to Announce Results of Successful Collaboration 2
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 ... the biometrics industry as Acuity Market Intelligence reports ... may finally be open. Acuity forecasts that intensifying ... devices that incorporate biometrics will drive a global ... billion biometric devices by 2020.   ...
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... grow beyond a limited size without an adequate blood ... researchers have sought to understand how a tumor,s vascular ... developing: If the vascular network never develops, the ... at the University of Massachusetts Medical School have discovered ...
... want, to paraphrase the Rolling Stones, but sometimes they can ... appear in the May issue of the American Naturalist ... of evolutionary changes in life on earth as well as ... yet the amount of variability seen among successive fossil assemblages ...
... of spaceflight will be used to examine how cells ... face of stress or damage. At 3:21 ... Cheryl Nickerson and her team, including Jennifer Barrila and ... low earth orbit aboard the space shuttle Discovery on ...
Cached Biology News:UMMS researchers uncover novel genetic pathway responsible for triggering vascular growth 2Ecologists receive mixed news from fossil record 2Out of this world: New study investigates infection of human cells in space 2Out of this world: New study investigates infection of human cells in space 3Out of this world: New study investigates infection of human cells in space 4
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
... modified nucleotide structure called a ?cap? ... most naturally-occurring eukaryotic mRNAs and many ... for a portion of the GTP ... reaction results in the synthesis of ...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
Biology Products: